North Star Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $595K | Hold |
|
|||||
|
2025
Q2 | $426K | Hold |
|
|||||
|
2025
Q1 | $352K | Sell |
|
|||||
|
2024
Q4 | $308K | Hold |
|
|||||
|
2024
Q3 | $360K | Hold |
|
|||||
|
2024
Q2 | $318K | Sell |
|
|||||
|
2024
Q1 | $226K | Sell |
|
|||||
|
2023
Q4 | $290K | Hold |
|
|||||
|
2023
Q3 | $268K | Hold |
|
|||||
|
2023
Q2 | $288K | Sell |
|
|||||
|
2023
Q1 | $308K | Hold |
|
|||||
|
2022
Q4 | $366K | Hold |
|
|||||
|
2022
Q3 | $308K | Sell |
|
|||||
|
2022
Q2 | $298K | Buy |
|
|||||
|
2022
Q1 | $330K | Hold |
|
|||||
|
2021
Q4 | $343K | Hold |
|
|||||
|
2021
Q3 | $381K | Buy |
|
|||||
|
2021
Q2 | $339K | Hold |
|
|||||
|
2021
Q1 | $282K | Hold |
|
|||||
|
2020
Q4 | $260K | Hold |
|
|||||
|
2020
Q3 | $291K | Hold |
|
|||||
|
2020
Q2 | $296K | Sell |
|
|||||
|
2020
Q1 | $327K | Hold |
|
|||||
|
2019
Q4 | $346K | Hold |
|
|||||
|
2019
Q3 | $241K | Sell |
|
|||||
|
2019
Q2 | $290K | Hold |
|
|||||
|
2019
Q1 | $374K | Buy |
|